STAT Plus: 23andMe’s chief scientific officer, a star in drug development, is leaving role
ERIC BARADAT/AFP/GETTY IMAGES
Richard Scheller, a Genentech veteran, has joined the Palo Alto-based BridgeBio (BBIO) as chairman of research and development.
Clinical and Molecular Allergy
Hace 17 horas
No hay comentarios:
Publicar un comentario